BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2011
View Archived Issues
Photocross-linked biosynthetic implants provide new tool for soft tissue reconstruction
Read More
Scientists genetically engineer E. coli to detect and kill P. aeruginosa
Read More
Human monoclonal antibody neutralizes influenza A group 2 viruses
Read More
Ranbaxy discloses new DPP IV/ACE inhibitors
Read More
New antitumor agents synthesized by Kyowa Hakko Kirin
Read More
Vertex discloses new inhibitors of PKC-theta
Read More
Novel antitumor agents disclosed by Chinese and U.S. team
Read More
New vitamin D analogues claimed
Read More
Cynapsus provides update on proposed acquisition of Adagio Pharmaceuticals
Read More
Afexa Life Sciences reports on LIP-01 trial in cholesterol management
Read More
Adamas Pharmaceuticals begins phase II/III study of ADS-5102
Read More
Shionogi advances acquisition of C&O Pharmaceutical Technology
Read More
Endo Pharmaceuticals terminates collaboration with Gruenenthal
Read More
FDA grants fast track status to DARA's KRN-5500
Read More
Kinex Pharmaceuticals begins phase I trial of KX2-391 in AML
Read More
Curis doses first patient in CUDC-101 head and neck cancer study
Read More
MAA accepted and NDA submitted for ridaforolimus
Read More
Hydrogen sulfide replacement may protect against complications of diabetes
Read More
Phase II trial of Cell Therapeutics' Opaxio opens enrollment
Read More
Furiex closes loan agreement to support development of clinical-stage products
Read More
NPS Pharmaceuticals submits CMC section of Gattex NDA to FDA
Read More
Antigen Express presents phase II data on anticancer vaccine AE-37 in breast cancer
Read More
FDA clears IND to conduct clinical studies of lasmiditan
Read More
FDA approves Marshall Edwards' IND for lead NADH oxidase inhibitor
Read More